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Abstract
Introduction: Periodontitis is one of the most widespread infectious diseases in humans. We previously promoted
significant periodontal tissue regeneration in swine models with the transplantation of autologous periodontal
ligament stem cells (PDLSCs) and PDLSC sheet. We also promoted periodontal tissue regeneration in a rat model
with a local injection of allogeneic bone marrow mesenchymal stem cells. The purpose of the present study is to
investigate the roles of the hepatocyte growth factor (HGF) and human dental pulp stem cells (DPSCs) in periodontal
tissue regeneration in swine.
Method: In the present study, we transferred an adenovirus that carried HGF gene into human DPSCs (HGF-hDPSCs)
under good manufacturing practice (GMP) conditions. These cells were then transplanted into a swine model for
periodontal regeneration. Twenty miniature pigs were used to generate periodontitis with bone defect of 5 mm in
width, 7 mm in length, and 3 mm in depth. After 12 weeks, clinical, radiological, quantitative and histological
assessment of regenerated periodontal tissues was performed to compare periodontal regeneration in swine
treated with cell implantation.
Results: Our study showed that injecting HGF-hDPSCs into this large animal model could significantly improve
periodontal bone regeneration and soft tissue healing. A hDPSC or HGF-hDPSC sheet showed superior periodontal
tissue regeneration compared to the injection of dissociated cells. However, the sheets required surgical placement;
thus, they were suitable for surgically-managed periodontitis treatments. The adenovirus-mediated transfer of the HGF
gene markedly decreased hDPSC apoptosis in a hypoxic environment or in serum-free medium, and it increased blood
vessel regeneration.
(Continued on next page)
* Correspondence: wuct@nic.bmi.ac.cn; slwang@ccmu.edu.cn
†Equal contributors
3Department of Experimental Hematology, Beijing Institute of Radiation
Medicine, 27 Taiping Road, Beijing 100850, P.R. China
1Molecular Laboratory for Gene Therapy & Tooth Regeneration, Beijing Key
Laboratory of Tooth Regeneration and Function Reconstruction, Capital
Medical University School of Stomatology, Tian Tan Xi Li No. 4, Beijing
100050, P.R. China
Full list of author information is available at the end of the article
© 2015 Cao et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Cao et al. Stem Cell Research & Therapy  (2015) 6:249 
DOI 10.1186/s13287-015-0244-5
(Continued from previous page)
Conclusion: This study indicated that HGF-hDPSCs produced under GMP conditions significantly improved
periodontal bone regeneration in swine; thus, this method represents a potential clinical application for
periodontal regeneration.
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Introduction
Periodontitis results in the destruction of tooth-
supporting tissues, such as bone, periodontal ligament,
and cementum [1]. To date, there is no ideal thera-
peutic approach for achieving optimal periodontal tis-
sue regeneration. Recent progress in tissue engineering
has shown that ex vivo expanded mesenchymal stem
cells (MSCs) are suitable for regenerative medicine, be-
cause of their potential for differentiating into multiple
lineages [2–6].
We previously generated a swine model of periodon-
titis [7]. We then demonstrated that significant peri-
odontal tissue could be regenerated by transplanting
periodontal ligament stem cells (PDLSCs) into the peri-
odontal defects in the swine model [7–9]. However,
sources of PDLSCs are limited, which greatly impedes
the clinical application of this approach. Alternatively,
adult dental pulp stem cells (DPSCs) are easily access-
ible because a large number of DPSCs are produced,
and the isolation methods are noninvasive compared
with other adult tissue sources. Based on their multipo-
tential differentiation properties, autologous DPSCs
have been used recently for clinical periodontal regen-
eration [10]. In addition, angiogenic growth factors, in-
cluding hepatocyte growth factor (HGF), have been
employed to induce periodontal regeneration [11]. HGF
was originally identified as a potent mitogen for mature
hepatocytes [12]. Later, it was shown that HGF could
stimulate mitogenic, morphogenic, and antiapoptotic
activities in a wide variety of cells, including most epi-
thelial and endothelial cells. Of note, HGF enhanced
the regeneration of several organs, including the heart,
liver, kidney, and lung [13, 14].
In this study, we cultured human dental pulp stem
cells (hDPSCs), and modified them by introducing an
adenovirus vector that harbored the HGF gene (Ad-
HGF), under good manufacturing practice (GMP)
conditions. We then transplanted these HGF gene-
modified hDPSCs (HGF-hDPSCs), by cell injection or
by cell sheet transplantation, into miniature pigs for
periodontal regeneration. With this approach, we eval-
uated the roles of HGF and DPSCs in periodontal tis-
sue regeneration. This preclinical study showed that,
when DPSCs modified with Ad-HGF were injected
into this large animal model, they could significantly
improve periodontal bone regeneration.
Methods
hDPSCs cultured under GMP
Normal human impacted third molars were collected
from male adults (19–29 years old) at the Dental Clinic
of Beijing Stomatological Hospital under approved
guidelines set by the Research Ethics Committee of
Capital Medical University, China. All patients gave
their written informed consent to participate. Tooth
surfaces were cleaned and cut around the cementum–
enamel junction (CEJ) with sterilized dental fissure burs
to reveal the pulp chamber. The pulp tissue was gently
separated from the crown and root, and then digested
in collagenase for 1 hour at 37 °C. Single cell suspen-
sions were obtained by passing the cells through a
70 μm strainer (Falcon; BD Labware, Franklin Lakes,
NJ, USA). The hDPSCs were cultured in a GMP-
compliant facility according to ISO 8 clean room stan-
dards. Briefly, our in-house qualification method
involves cleaning and decontamination for facilities
such as water baths, incubators, refrigerators, freezers,
and centrifuges. Temperature and gases are also con-
tinuously monitored in the equipment through a wire-
less network system operated by contract vendors. The
equipment in the facility is monitored on a daily basis.
External certified vendors calibrate the biosafety cabi-
nets and monitor air as per ISO standards and perform
a viable particle count in clean rooms and the biosafety
cabinet. Periodic calibrations are done to ensure func-
tioning of the equipment as stipulated. External ven-
dors also perform calibration and qualification of
pipettes. Testing of adventitious agents is done by clin-
ically certified laboratories. The facility was equipped
with class II and class III biosafety cabinets and all
other standard tissue culture equipment. We used
xenobiotic-free cell culture reagents for culturing cells,
as follows: animal origin-free collagenase (Worthington
Biochemical Corporation, Lakewood, NJ, USA), CELLstart,
EZPassage Tool, Ca/Mg-free HBSS, D/F12, TrypLE, xeno-
free B27, N2 supplement, MSCGM-CD, and ProFreeze
CDM (Invitrogen/Gibco, Carlsbad, CA, USA), human
serum (Innovative Research, Inc., Novi, MI, USA), basic
fibroblast growth factor-2 (bFGF-2; Peprotech, Rocky Hill,
NJ, USA), TeSR2, which includes high levels of bFGF and
transforming growth factor beta (TGF-β; Stem Cell Tech-
nologies, Vancouver, BC, Canada), and Nutristem Stemedia
(Stemgent, San Diego, CA, USA). Nutristem Stemedia
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consisted of human recombinant insulin, human serum
albumin, transferrin, human fibroblast growth factor, and
TGF-β.
To identify putative stem cells, single cell suspensions
(1 × 105 cells) were seeded onto 10 cm culture dishes
(Corning Costar, Cambridge, MA, USA) in alpha-
modified Eagle’s medium (a-MEM; Gibco, Invitrogen),
supplemented with xenobiotic-free cell culture reagents;
cells were then incubated at 37 °C in 5 % carbon dioxide.
Colony-forming efficiency was assessed on day 14. Ag-
gregates of 50 cells or more were scored as colonies. All
cells in this study were used after three or four passages.
For each experiment, all hDPSCs were used after the
same number of passages. MSC characterizations, in-
cluding surface molecule expression profiles and multili-
neage differentiation, were performed as described
previously [7].
Adenoviral vectors and gene transfection
We constructed replication-deficient recombinant adeno-
virus vectors that carried the green fluorescent protein
(Ad-GFP; control) or human HGF (Ad-HGF) [14]. All
adenovirus vectors were constructed with the AdEasy sys-
tem (Stratagene, La Jolla, CA, USA). Briefly, the human
HGF gene or GFP gene was amplified by PCR and
inserted into the pShuttle-CMV (Stratagene, LaJolla, CA,
USA), obtaining the pShuttle plasmid pShuttle-HGF or
pShuttle-GFP. pShuttle-HGF and pShuttle-GFP were then
used to generate Ad-HGF and Ad-GFP, respectively, ac-
cording to the manual accompanying the AdEasy system.
All adenovirus vectors were purified by double CsCl dens-
ity gradient ultracentrifugation, dissolved in storage buffer
(Hanks’ buffer, 10 % glycerol), and stored at –80 °C. Viral
particle (VP) numbers and infectious titers (infectious
units/ml) were determined as described previously; and
the multiplicity of infection was calculated from infectious
titers. The final number of plaque-forming units was de-
termined by titration on human embryonic kidney 293
cells under an agarose overlay.
The hDPSCs were infected with the adenovirus vectors
at different multiples of infection (MOIs), in the 50–400
range. The transfection efficiency was assessed with GFP
as the reporter molecule, and the infection efficiency
was determined by flow cytometry.
Enzyme-linked immunosorbent assay for HGF expression
HGF-hDPSCs were assayed for HGF expression by
enzyme-linked immunosorbent assay (ELISA). Briefly, cell
supernatants were collected at different time points (up to
14 days) after transfection. ELISA was conducted with a
primary mouse monoclonal antibody against human HGF,
and a secondary horseradish peroxidase-labeled goat anti-
mouse immunoglobulin. Detection was performed with a
spectrophotometric o-phenylenediamine color-developing
system. The optical density was measured at 405 nm with
a Microplate Manager 450 (Bio-Rad, Hercules, California,
USA).
Determination of apoptotic cells
hDPSC apoptosis was evaluated with the Annexin-V-
FLUOS apoptosis staining kit (Roche Diagnostic, Rotk-
reuz, Switzerland). A total of 106 cells were washed with
phosphate-buffered saline (PBS; Invitrogen) and centri-
fuged at 200 × g for 5 minutes. The cell pellet was resus-
pended in 100 ml Annexin-V-FLUOS labeling solution,
incubated, and analyzed with flow cytometry.
Measurement of capillary density in periodontal soft
tissues
Four miniature pigs were used to assess the effect of
HGF-hDPSCs on the vascularization in periodontal tis-
sues. The present study was approved by the animal care
and use committee of Capital Medical University (refer-
ence number: AEEI-2015-089). The animal care and ex-
perimental procedures were carried out in accordance
with guidelines of the Beijing Experimental Animal
Management Ordinance. Approximately 1 × 107 hDPSCs
in 0.6 ml of 0.9 % NaCl were injected at three sites
(approximately 0.2 ml per site): the mesial side, the
distal side, and the middle side of the buccal gingival
tissues of one mandible first molar of four pigs. The
same dose of HGF-hDPSCs was injected using the
same procedure into the other mandible first molar of
four pigs. At 4 weeks post injection, we located the al-
veolar bone crest by bone sounding, and we deter-
mined its biological width. Connective tissue samples
were then removed from the gingival margin to the
top of the alveolar bone crest. Subsequently, all sam-
ples were sectioned in the bucco-lingual direction and
then stained with hematoxylin and eosin (H & E). In
each sample, five regions of interest (200× objective)
were randomly imaged. The capillary vessels count
was performed in these five randomly selected high-
power (200× objective) microscopic fields (HPFs). The
number of capillary vessels was counted by two dis-
tinct observers. As an internal control (intraobserver
variation), the capillary vessels count for all samples
was repeated by the same observer (YC). For external
control (interobserver variation), all samples were
recounted by a second independent, blinded observer
(CZ). All investigators were blinded to the status of
the animal. The five values were averaged to deter-
mine the number of capillary vessels per field for each
sample.
Flow cytometric analysis
To examine stem cell surface molecule expression in
hDPSCs, 2.5 × 105 third-passage cells were placed in
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1.5 ml eppendorf tubes and fixed with 4 % paraformalde-
hyde for 15 minutes. Primary anti-STRO-1 and anti-
CD146 antibodies were added to the tubes and incu-
bated at room temperature for 1 hour. Next, fluorescein
isothiocyanate (FITC)-conjugated or phycoerythrin (PE)-
conjugated secondary antibodies were added, and the
mixtures were incubated at room temperature in the
dark for 45 minutes. The percentages of cells positively
stained with STRO-1 and CD146 were assessed with
fluorescence-activated cell sorting, in a FACSCalibur
flow cytometer (Becton Dickinson Immunocytometry
Systems, San Jose, California,USA).
Carboxyfluorescein diacetate succinimidyl ester staining
Cell-cycle length was analyzed with carboxyfluorescein
diacetate succinimidyl ester (CFSE) staining. The cells
were harvested, washed with PBS + 0.1 % bovine serum
albumin (BSA), and then cold absolute ethanol was
added during vortexing of the cells. The cells were sus-
pended in PBS + 0.1 % BSA and stained for 10 minutes
at 4 °C with 5 μM CFSE (b21888; Sigma,
St.Louis., MO, USA ). The staining was quenched by
adding 4 volumes of ice-cold culture medium + 1 % BSA
(5 minutes), and the cells were then washed twice with
PBS at 4 °C. The stained cells were reintroduced into
culture for 24 or 48 hours. The cells were then har-
vested, and the intensity of CFSE staining was assessed
by fluorescence microscopy. The number of cells stained
was quantified by flow cytometry with a FACScan (Bec-
ton-Dickinson, Heidelberg, Germany) and the results
were analyzed with Flowing software (Version 2.5, Jo-
seph Trotter, Scripps Research Institute, La Jolla, CA,
USA).
Multilineage differentiation potential
hDPSCs were cultured in adipogenic differentiation
media and in osteogenic differentiation media. Oil Red
O stain and Alizarin Red stain, respectively, were used
to determine hDPSC differentiation potentials.
Ectopic mineralized tissue formation analysis
The present study was approved by the Animal Care
and Use Committee of Capital Medical University. The
animal care and experimental procedures were carried
out in accordance with the guidelines of the Beijing
Experimental Animal Management Ordinance. In the
control group, hydroxyapatite/tricalcium phosphate
(HA-TCP) was transplanted subcutaneously into the
dorsal region of immunodeficient female mice (BALB/c
Nude, 6–8 weeks old). In the two experimental groups
(n = 6), complexes of HA-TCP and hDPSCs or com-
plexes of HA-TCP and HGF-hDPSCs were transplanted
with the same procedure. The mice were allowed to re-
cover for 12 weeks, and were then sacrificed for analysis.
The dissected tissues were fixed in 4 % formalin for
24 hours, decalcified with buffered 10 % ethylenedi-
aminetetraacetic acid (EDTA, pH 8.0), and embedded in
paraffin. The paraffin blocks were sectioned at a thick-
ness of 5 μm and stained with H & E. To quantify bone
formation, the area of mineralized tissue was assessed in
three consecutive slices with the Image Pro 5.0 system
(Media Cybernetics, Rockville, MD, USA). The bone for-
mation area was expressed as the percentage of bone tis-
sue in each section. The mean value of three
measurements was calculated for each implant, and this
value was used to calculate the mean percentage of bone
formation observed in each group.
Generation of the periodontitis model
Twenty inbred male Wuzhishan miniature pigs, aged
12 months (sexual maturity stage), body weights of
30−40 kg, were obtained from the Institute of Animal
Science at the Chinese Agriculture University (Beijing,
China). All surgical procedures were performed under
general anesthesia, achieved with a combination of
6 mg/kg ketamine chloride and 0.6 mg/kg xylazine
(intramuscular injection). After each procedure, animals
were moved to a climate-controlled and light-controlled
environment and allowed free access to food (liquid food)
and water.
We generated a total of 40 periodontitis lesions in the
first molars, as described previously [8]. After clinical as-
sessment, a mucoperiosteal flap was raised and alveolar
bone was removed using a surgical bur to create experi-
mental periodontal bone defects in the mesial region of
the maxilla and mandibular first molars. The alveolar
bone defect was 5 mm in width, 7 mm in length, and
3 mm in depth, and notch-shaped marks were made on
the root surface at the CEJ and the level of the floor of
the defect. Three walls of the bone defect were alveolar
bone, and the root surface in the bone defect was instru-
mented using Gracey curettes (Shanghai Kangqiao
Dental Instruments Factory, Shanghai, China) to re-
move all periodontal ligaments as well as cementum to
expose the dentin surface between two notch-shaped
marks.
After creating these defects, the 20 miniature swine
(two defects each) were randomly assigned to five treat-
ment groups, with four miniature swine per group (eight
defects per group). The control group received no treat-
ment. The hDPSC injection group was injected with ap-
proximately 1 × 107 hDPSCs in 0.6 ml of 0.9 % NaCl at
three sites (approximately 0.2 ml per site): the mesial
side of the bone defect, the distal side of the bone defect,
and the middle of the bone defect. The shape of the
bone defect was detected by periodontal probe (bone
sounding). The tip of the needle was stopped at the bot-
tom of the bone defect beneath the periosteum. hDPSCs
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were injected into the bottom of the periodontal bone
defects beneath the periosteum. The HGF-hDPSC injec-
tion group received an injection of approximately 1 ×
107 HGF-hDPSCs with the same procedure as that de-
scribed for the hDPSC injection group. Groups 4 and 5
received transplantations of hDPSC sheets and HGF-
hDPSC sheets, respectively. These sheets were prepared
for tissue regeneration in vivo as described in our previ-
ous report [9]. Briefly, 1.0 × 105 hDPSCs or HGF-
hDPSCs were cultured in 60 mm dishes with 20.0 μg/ml
vitamin C for 10–15 days until they formed a sheet; each
sheet contained approximately 1 × 107 hDPSCs or HGF-
DPSCs. One sheet was used for each transplantation. All
sheets were transplanted with flap surgery. At 12 weeks
after transplantation, all animals were sacrificed. Tissue
samples were harvested, fixed with 4 % paraformaldehyde
(Sigma-Aldrich Corp., St.Louis., MO, USA ), and assessed
histologically.
Clinical and radiological evaluations
Clinical assessments, including the probing depth (PD)
and attachment loss (AL), were performed on all experi-
mental teeth just before transplantation (week 0) and
post transplantation at week 12. The PD values were
established with a Williams periodontal probe (Shanghai
Kangqiao Dental Instruments Factory).
Bone regeneration was examined by computed tomog-
raphy (CT) (Siemens, Erlangen, Germany). CT was per-
formed pre transplantation (week 0) and at 12 weeks
post transplantation. The CT scanning conditions were
120 kV, 250 mA, a 0.75 mm slice thickness, and a 3-
second slice acquisition time. Data were stored in the
standard Dicom 3.0 format. Three-dimensional CT im-
ages were reconstructed to assess tissue regeneration.
Images in the default Dicom format were introduced
into Mimics software (Mimics, Materialise NV, Leuven,
Belgium). Threshold values were set according to the
Bone (CT) Scale in Mimics. Three-dimensional models
were reconstructed with Optimal, a setting in Mimics.
An ASCII stereolithography (STL) file of the bone was
imported into Geomagic Studio (Geomagic, Morrisville,
NC,USA).
Quantitative and histological assessments of regenerated
periodontal tissues
At 12 weeks after transplantation, all animals were sacri-
ficed and samples from the experimental areas were har-
vested and fixed with 4 % formaldehyde. The heights of
new bone regeneration were measured with a Williams
periodontal probe: the distance from the top of newly
formed bone to the notch-shaped mark in the CEJ made
during the operation. Each sample was measured at
three different positions between the buccal and lingual
sides. The mean of these three values was recorded, and
the height of new bone regeneration was calculated as
7 mm minus this mean value [7]. To enable quantitative
comparisons among three groups, the proportion of
bone volume that occupied the virtual space of the de-
fect was determined with Simplant® software (Dentsply
Implants, Waldham, MA, USA).
Next, the harvested samples were assessed histologi-
cally. Samples that had been fixed were subsequently
decalcified with buffered 10 % EDTA (pH 8.0) and em-
bedded in paraffin. For histopathological assessments,
sections (5 μm) of the bone defect region were cut in
the buccal–lingual direction. All sections were then
deparaffinized and stained with H & E. For histomor-
phometric analysis, central cuts of the samples were
used for assessing bone formation; sections near the lat-
eral limits of the defect were abandoned. Single images
disclosing the center part of the defect area were super-
imposed to an overview image using Adobe Photoshop
(Adobe Photoshop CS6; Adobe, Dublin, Ireland). To
quantify bone formation, the extent of bone present in
each section was evaluated semiquantitatively with histo-
morphometric techniques, as described previously [8]. In
each group, 10 representative areas were evaluated at 5×
magnification by a responsible researcher (CZ) blinded
to the group assignment of the specimen. The area of
bone formation was expressed as the percentage of bone
present in the periodontium of the sections.
Statistical analysis
All statistical calculations were performed with SPSS13
statistical software (SPSS, Chicago, IL, USA). Quantita-
tive data were expressed as the mean ± standard devi-
ation (SD). Statistical significance was determined by the
independent sample test or analysis of variance. P ≤0.01
was considered significant.
Results
Intrinsic features of hDPSCs transfected with Ad-HGF in
GMP conditions
The cells isolated from dental pulp tissue and grown into
colonies under GMP conditions exhibited a typical fibro-
blast-like morphology (Additional file 1: Figure S1A, B).
The infection efficiency of Ad-HGF reached 99.64 % in
hDPSCs when the MOI was 150:1 (Fig. 1a, b). We deter-
mined whether the cultured MSCs transfected with Ad-
HGF or Ad-GFP could release soluble HGF protein by
assaying conditioned medium with the ELISA method.
We detected a peak of 88 ng/ml HGF in HGF-hDPSC
medium on day 4 post transfection (Fig. 1c). Flow cytome-
try analysis indicated that HGF-hDPSCs were uniformly
positive for STRO-1, CD73, CD90, CD105, and CD146;
additionally, they were negative for CD31, CD45, and
HLA-DR (Fig. 1d). This profile was similar to that of their
Ad-GFP-transfected counterparts; thus, the phenotypic
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profile of transfected cells was unaffected by HGF expres-
sion. Moreover, CFSE staining indicated that the prolifera-
tion efficiency of hDPSCs was not altered by HGF
transduction (Additional file 1: Figure S1C). In vitro
differentiation assays demonstrated that HGF-hDPSCs
possessed osteogenic and adipogenic capabilities, as ex-
pected (Additional file 1: Figure S1D, E). When tissues
transplanted with normal hDPSCs (Fig. 2a) were com-
pared with tissues transplanted with HGF-hDPSCs
(Fig. 2b), significantly more capillaries were observed in
the tissues transplanted with HGF-hDPSCs (Fig. 2c).
Moreover, when cells were exposed to a hypoxic envir-
onment or to serum-free media, apoptosis was ob-
served in a markedly lower percentage of HGF-hDPSCs
than hDPSCs (Fig. 2d).
Ectopic mineralized tissue formation analysis
At week 12 after transplantation, mineralized tissue
combined with collagen fiber was more abundant in the
hDPSC group (Fig. 3a) and the HGF-hDPSC group
(Fig. 3b) compared with the control group (Fig. 3c). The
highest amount of mineralized tissue had formed in the
HGF-hDPSC group (Fig. 3b, d).
hDPSC-mediated periodontal tissue regeneration in swine
We generated periodontitis lesions in miniature swine,
and then transplanted hDPSCs or HGF-hDPSCs into the
defects. We transplanted either cell sheets or disasso-
ciated cells to compare their capacities for soft tissue
healing and alveolar bone regeneration. The animals
were sacrificed at 12 weeks post transplantation, and
intraoral photographs were acquired. We found that at
12 weeks after transplantation only limited periodontal
soft tissues were regenerated in the control group
(Fig. 4A, A′). In contrast, marked periodontal tissue for-
mation was found in the hDPSC injection group (Fig. 4B′)
and the HGF-hDPSC injection group (Fig. 4C′), but the
tissues were not restored to healthy levels. However, peri-
odontal soft tissue in the hDPSC sheet group (Fig. 4D, D′)
and the HGF-hDPSC sheet group (Fig. 4E, E′) was
Fig. 1 Characterization of hDPSCs cultured under GMP conditions. a Microscopic image (left) and fluorescence microscopic image (right) of MSCs
transfected with Ad-GFP at a MOI of 150 for 48 hours. b Transfection efficiency of MSCs transfected with Ad-GFP. Cells were transfected at different
MOI levels and cultured for 48 hours. Transfection efficiency was determined by flow cytometry. c Adenovirus-mediated expression of HGF in hDPSCs
infected with Ad-HGF at an MOI of 150. Conditioned medium was collected at different time points, and HGF content was determined by
ELISA. *P <0.05 for hDPSCs infected with Ad-HGF compared with Ad-GFP control. d Flow cytometric analysis of hDPSCs and HGF-hDPSCs shows expression
of cell markers CD73, CD105, CD90, and CD146, and negative results for HLA-DR and CD45. d days, GFP green fluorescence protein, hDPSC human dental
pulp stem cell, HGF hepatocyte growth factor, PE phycoerythrin
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restored to close to normal levels. Three-dimensional CT
images also indicated that limited bone formation oc-
curred in the control group (Fig. 4a, a′). In contrast,
marked bone regeneration occurred in the hDPSC injec-
tion group (Fig. 4b, b′), the HGF-hDPSC injection group
(Fig. 4c, c′), the hDPSC sheet group (Fig. 4d, d′), and the
HGF-hDPSC sheet group (Fig. 4e, e′). At this time, the AL
values were 4.0 ± 0.6 mm in the hDPSC injection group,
3.8 ± 0.5 mm in the HGF-hDPSC injection group, 3.5 ±
0.7 mm in the hDPSC sheet group, 3.5 ± 1.3 mm in the
HGF-hDPSC sheet group, and 7.7 ± 0.7 mm in the un-
treated control group (Fig. 5b). Statistical analysis indi-
cated that both the hDPSC sheet treatment and the
hDPSC injection significantly improved periodontal tissue
regeneration compared with the control group (Fig. 5).
The heights of newly regenerated bone were significantly
higher in all treatment groups compared with the control
group (Fig. 5c). Based on the CT scan and three-
dimensional CT images, the regenerated alveolar bone
volumes in the hDPSC injection group, the HGF-hDPSC
injection group, the hDPSC sheet group, and the HGF-
hDPSC sheet group were 38.2 ± 5.3 mm3, 47.3 ± 4.9 mm3,
58.8 ± 3.8 mm3, and 69.3 ± 3.9 mm3, respectively. The
bone volumes in all treatment groups were significantly
larger than the volume in the control group (0.5 ±
2.3 mm3, Fig. 5d).
The 12-week posttransplantation experimental tissue
samples were sectioned in the buccal–lingual direction
and stained with H & E to provide a view of the entire
section. New periodontal tissue regeneration within the
periodontal defects was significantly less pronounced in
the control group (Fig. 6A) compared with the regener-
ation observed in the treatment groups (Figs. 6B–E).
Both bone and periodontal ligament tissues were re-
generated within the periodontal defect areas in all of
the hDPSC groups (Figs. 6b–e). Alveolar bone regen-
eration was also more pronounced in the HGF-hDPSC
injection group (Fig. 6C), the hDPSC sheet group
(Fig. 6D), and the HGF-hDPSC sheet group (Fig. 6E)
than in the control group (Fig. 6A, F). Newly formed
Sharpey’s fibers had penetrated into the newly regen-
erated mineral tissues in the HGF-hDPSC injection
Fig. 2 hDPSCs that overexpressed HGF prevented apoptosis and promoted neovascularization in vivo. a, b Representative photomicrographs of
histological sections of periodontal soft tissues from a the hDPSC injection group and b the HGF-hDPSC injection group. Blue arrows, location of
capillaries. c The number of capillaries in ischemic periodontal soft tissues was significantly higher in the HGF-hDPSC injection group compared
with the hDPSC group (*P <0.05). d Annexin V staining for apoptosis showed that more apoptotic cells were found in the hDPSC injection group
than in the HGF-hDPSC injection group (*P <0.05). hDPSC human dental pulp stem cell, HGF hepatocyte growth factor
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group (Fig. 6c), the hDPSC sheet group (Fig. 6d), and
the HGF-hDPSC sheet group (Fig. 6e). The percent-
ages of periodontal bone in the hDPSC injection,
HGF-hDPSC injection, hDPSC sheet, and HGF-
hDPSC sheet groups were significantly higher than
that of the control group (*P <0.01). The percentages
of periodontal bone were higher in the HGF-hDPSC
injection, hDPSC sheet, and HGF-hDPSC sheet groups
than in the hDPSC injection group (ΔP <0.01). The
percentages of periodontal bone were higher in the
hDPSC sheet and HGF-hDPSC sheet groups than in
the HGF-hDPSC injection group (#P <0.01) (Fig. 6f ).
Discussion
The present study investigated the feasibility of trans-
planting hDPSC/HGF-hDPSCs and hDPSC/HGF-hDPSC
sheets for treating periodontitis in a large animal model.
At 12 weeks after transplantation, we found that new al-
veolar bone had regenerated in the hDPSC/HGF-hDPSC
injection groups and the hDPSC/HGF-hDPSC sheet
groups. In contrast, in the control group, periodontal de-
fects were largely filled with fibrous tissue and epithe-
lium, and limited, irregular new attachment was
observed. These results suggested that the hDPSC injec-
tions and hDPSC sheets contributed significantly to peri-
odontal bone regeneration. Notably, the HGF-hDPSC
injection exhibited more periodontal tissue regeneration
capacity than the hDPSC injection. CT scan analyses
showed a significantly larger volume of periodontal al-
veolar bone in the HGF-hDPSC injection group than in
the hDPSC injection group. However, based on intraoral
photographs acquired at 12 weeks post injection, the
hDPSC and HGF-hDPSC injections did not restore soft
tissues to healthy levels, in contrast to our findings in
the hDPSC and HGF-hDPSC sheet groups. CT scan ana-
lyses also showed that the volumes of periodontal alveo-
lar bone in the hDPSC and HGF-hDPSC sheet groups
were significantly larger than those in the hDPSC and
HGF-hDPSC injection groups. Periodontal soft tissues
were healed to nearly normal levels in the HGF-hDPSC/
hDPSC sheet group. This result suggested that the HGF-
hDPSC/hDPSC sheet could be the best regenerative
method of those tested.
Our research group previously generated a swine
model of periodontitis. In that model, we induced sig-
nificant periodontal tissue regeneration by treating with
PDLSCs mixed with HA/TCP scaffolds [7], allogeneic
PDLSC sheets [8], or vitamin C-treated PDLSC sheets
[9]. Compared with PDLSCs, DPSCs represented a
richer tissue source and were easier to isolate. It was
previously reported that autologous DPSCs could be
used to regenerate intrabony periodontal tissues to
Fig. 3 Ectopic mineralized tissue formation analysis. a–c Mineralized tissue formation was observed in both the hDPSC a and HGF-hDPSC b groups
compared with control c, but more was observed in the HGF-hDPSC group b. d Compared with the control group (HA-TCP alone), more
mineral tissue was formed in both the hDPSC and HGF-hDPSC groups (*P <0.01), but more was formed in the HGF-hDPSC group than in
the hDPSC group (#P <0.01). Red arrow, HA-TCP; yellow arrow, collagen fiber. Scale bar = l00 μm. 12w 12 weeks, hDPSC human dental pulp
stem cell, HGF hepatocyte growth factor, M mineralized tissue
Cao et al. Stem Cell Research & Therapy  (2015) 6:249 Page 8 of 13
restore defects [10]. We hypothesized that a local injec-
tion of DPSCs might allow transplanted cells to migrate
into even narrow, small recipient sites of local periodon-
tal defects, including periodontal intrabony defects,
without damaging soft tissues or creating an osteotomy.
This local injection is an easy, mildly-invasive approach
for regenerating lost bone, cementum, and periodontal
ligament, but at the same time it can preserve soft tissue
attachments, which may be particularly important when
treating mild periodontitis. Cell injection therapy is a
commonly used approach for treating a variety of dis-
eases, including the regeneration of tissues after a spinal
cord injury or myocardial infarction [15, 16]. Our re-
search group previously injected a BMMSC suspension
into a rat periodontitis model and demonstrated that a
local injection of BMMSCs could repair tissues that were
defective due to periodontitis [17]. In this study, new
periodontal tissues were regenerated 12 weeks after the
hDPSC/HGF-hDPSC injections.
Cell sheets [18], which were designed to avoid the
shortcomings of traditional tissue engineering, have been
used extensively and were shown to be beneficial for
many clinical applications, such as cell transplantation
and tissue regeneration. When cultured cells are har-
vested as intact sheets, along with their corresponding
extracellular matrix (ECM), they can be easily attached
to host tissues, even wound sites, with minimal cell loss.
A cell sheet has a three-dimensional macrostructure that
mimics the physiological functions of the ECM. Cell
sheets have the advantage of eliminating the use of scaf-
folds; thus, they avoid strong inflammatory responses
that are induced when biodegradable scaffolds are
broken down. In this study, new alveolar bone and peri-
odontal soft tissues were regenerated to nearly normal
Fig. 4 Regeneration of tissue in periodontal defects mediated by transplanted hDPSCs. Intraoral photographs were acquired A–E before
transplantation or A′–E′ 12 weeks after transplantation. A′ Only limited periodontal tissues were regenerated in the control group (yellow
dotted line). Marked periodontal tissue formation was found in B′ the hDPSC injection group and C′ the HGF-hDPSC injection group, but they
did not restore tissues to healthy levels (yellow dotted line). Periodontal tissue regeneration mediated by D′ the hDPSC sheet and E′ the HGF-hDPSC
sheet achieved close to normal tissue levels (yellow dotted line). Three-dimensional CT images were acquired a–e before transplantation and a′–e′
12 weeks after transplantation. a′ Only limited bone regeneration was observed in the control group, but marked bone formation was observed b′ in
the hDPSC injection group, c′ the HGF-hDPSC injection group, d′ the hDPSC sheet group, and e′ the HGF-hDPSC sheet group after cell transplantation
(red dotted line). Yellow dotted line, gingival margin; red dotted line, bone margin. hDPSC human dental pulp stem cell, HGF hepatocyte growth factor
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levels at 12 weeks after the administration of cell sheets.
However, effective cell sheet transplanting requires open
flap surgery, which may be traumatic for patients; such
treatment is thus more suitable for combination with
surgical periodontal treatment.
We also transplanted HGF-modified hDPSCs for treat-
ing periodontitis in miniature pigs to evaluate the role of
HGF in periodontal tissue regeneration. HGF, a member
of the endothelial growth factor family, has been shown
to induce angiogenesis in vivo [13]. It is well known that
HGF enhances the regeneration of organs, such as the
liver, kidney, and lung [14]. In addition to its angiogenic
activity [19–21], it has been well documented that HGF
can prevent cell death. Because of its inhibitory effect on
fibrosis, HGF protein delivery or HGF gene therapy ap-
proaches improved renal fibrosis and renal dysfunction
[22]. HGF is also a healing factor, with cytoprotective ef-
fects in conditions associated with inflammatory dis-
eases, including periodontitis. A number of studies
demonstrated that HGF levels were elevated in patients
with chronic periodontitis [23, 24]. However, despite
high concentrations, HGF may appear in a form with re-
duced biological activity at local inflammation sites [25].
Previous studies have emphasized the importance of
Fig. 5 Clinical qualitative assessments of periodontal and bone tissues regenerated with dissociated cells and cellular sheet transplantations in
miniature pigs. a, b Clinical assessments of the periodontal tissues. At week 0, there was no significant difference in a PD or b AL among the five
groups. At 12 weeks post transplantation, the PD and AL were significantly improved in the groups that received an hDPSC injection, HGF-hDPSC
injection, hDPSC sheet, or HGF-hDPSC sheet, compared with those in the control group (untreated) (*P <0.01, n = 8). c Bone regeneration height
was greatest in the HGF-hDPSC sheet group, but bone regeneration heights were greater in all treatment groups compared with the control
group (*P <0.01). The bone regeneration heights in the hDPSC sheet and HGF-hDPSC sheet groups were greater than those in the hDPSC injection
(ΔP <0.01) and in the HGF-hDPSC injection (#P <0.01) groups. d Bone regeneration volume was largest in the HGF-hDPSC sheet group. Bone regeneration
volumes in the hDPSC injection, HGF-hDPSC injection, and hDPSC sheet groups were also larger than that in the control group (*P <0.01).
Bone regeneration volumes were larger in the hDPSC sheet and HGF-hDPSC sheet groups than in the hDPSC injection group (ΔP <0.01). Bone
regeneration volumes were larger in the hDPSC sheet and HGF-hDPSC sheet groups compared with the HGF-hDPSC injection group (#P <0.01). hDPSC
human dental pulp stem cell, HGF hepatocyte growth factor, w weeks
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endogenous, biologically-active HGF in regeneration and
healing during chronic inflammatory diseases. Several
studies have shown that, in the cardiovascular system
[26–29], endogenous HGF was present in a reduced
biologically-active form. However, administration of ex-
ogenous HGF was shown to prevent tissue fibrosis and
dysfunction in chronic disease models [30–32].
In the present study, because hDPSCs did not secrete
sufficient angiogenic factors to induce angiogenesis in
vivo, we transduced the human HGF cDNA into
hDPSCs with the adenoviral system, which achieved high
HGF secretion in vitro. Autocrine HGF did not suppress
the differentiation potential of hDPSCs in vitro. In this
study, we also found that, when HGF-hDPSCs and
Fig. 6 Whole-view histopathological assessments of periodontal tissue regeneration in H & E stained sections. New periodontal tissue regeneration
within the periodontal defect is shown for the A control group, B hDPSC injection group, C HGF-hDPSC injection group, D hDPSC sheet group, and E
HGF-hDPSC sheet group. New bone, cementum, and periodontal ligament were regenerated in the periodontal defect areas that received a
no treatment, or treatments of b hDPSC injections, c HGF-hDPSC injections, d hDPSC sheets, or e HGF-hDPSC sheets. Alveolar bone regeneration in A
the control group was much less pronounced than that observed in the C HGF-hDPSC injection group, D hDPSC sheet group, and E HGF-hDPSC sheet
group. Newly formed Sharpey’s fibers were observed penetrating into the newly regenerated cementum in the c HGF-hDPSC injection group, d hDPSC
sheet group, and e HGF-hDPSC sheet group. F The percentages of periodontal bone in the hDPSC injection, HGF-hDPSC injection, hDPSC sheet, and
HGF-hDPSC sheet groups were significantly higher than that of the control group (*P <0.01). The percentages of periodontal bone were higher in the
HGF-hDPSC injection, hDPSC sheet, and HGF-hDPSC sheet groups than in the hDPSC injection group (ΔP <0.01). The percentages of periodontal bone
were higher in the hDPSC sheet and HGF-hDPSC sheet groups than in the HGF-hDPSC injection group (#P <0.01). B bone, C cementum, CEJ,
cementum–enamel junction, D dentin, HAB height of alveolar bone, hDPSC human dental pulp stem cell, HGF hepatocyte growth factor, PDL
periodontal ligament
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hDPSCs were subjected to a hypoxic environment or
serum-free media, apoptosis occurred markedly less fre-
quently in HGF-hDPSCs than in hDPSCs. This result
suggested that HGF functioned as a protective factor.
Our results confirmed that the HGF-hDPSC injection
and HGF-hDPSC sheet promoted the growth of signifi-
cantly larger volumes of periodontal alveolar bone than
the hDPSC injection and untreated control. However,
the biological activity of the HGF secreted by implanted
hDPSCs requires further investigation. The results from
the present study showed that HGF-hDPSC injection
promoted the growth of significantly larger volumes of
periodontal alveolar bone than the hDPSC injection,
while DPSC sheets and HGF-DPSC sheets did not make
a significant difference in clinical outcomes. In general,
the effect of periodontal regeneration using DPSC sheets
was better than that for DPSC injection. Since cell sheet
transplanting requires open flap surgery, which may be
traumatic for patients, DPSC injection with or without
HGF transfection should be considered as an effective
non-surgical therapy; DPSC sheets are an appropriate
surgical therapy for periodontitis.
Conclusions
This study supported the feasibility of using hDPSCs
cultured under GMP guidelines as a potential stem cell
technology for periodontal regeneration. Our data dem-
onstrated that hDPSC/HGF-hDPSC injections and
hDPSC/HGF-hDPSC sheets provided appropriate ther-
apy for periodontitis, by inducing significant periodontal
bone regeneration and soft tissue recovery.
Additional file
Additional file 1: Figure S1. Showing biological functions of hDPSCs
and HGF-hDPSCs under GMP conditions. Representative phase-contrast
microscopic photographs of hDPSCs after culturing for A 7 days (first
passage) and B 18 days (fourth passage); the morphology is typical of
fibroblast-like cells. C The CFSE test indicated that the proliferation index
was not significantly different between the hDPSCs and HGF-hDPSCs. D,
E The differentiation potential of hDPSCs is demonstrated by D staining
with Oil Red O and E staining with Alizarin Red S. (TIF 2169 kb)
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